Skip to content

Evaluation of a New Airway Device - the YO2(R) Catheter in Patients Under Sedation

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01709890
Enrollment
50
Registered
2012-10-18
Start date
2012-12-31
Completion date
Unknown
Last updated
2012-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients Undergoing Anesthesiologist-administered iv Sedation During Diagnostic/ Therapeutic Procedures

Brief summary

Patients under sedation not uncommonly develop upper airway obstruction or other respiratory complications and no airway device is available to provide reliable maintenance of the airway at present. I believe the YO2(R)airway catheter can improve the maintenance of patent airway in most sedated patients and improve O2 delivery to the airway. In addition it may also greatly facilitate the monitoring of expired CO2, which is widely recognised as the most important monitor of adequacy of breathing, yet frequently impossible to perform satisfactorily in sedated patients at the moment.

Interventions

DEVICEYO2(R) catheter

Sponsors

The University of Hong Kong
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Adult patient, age \>18 and \<80 2. Undergoing anesthesiologist-administered sedation for diagnostic/ therapeutic procedures

Exclusion criteria

1. Expected procedure require access to or involve the nostrils. 2. Obesity (BMI \>=30) 3. Chronic lung diseases (e.g. COPD) associated with chronic hypoxia 4. Pregnant or lactating women. 5. Known chronic liver or renal disease. 6. Mentally incapable of providing informed consent

Countries

China

Contacts

Primary ContactKwok F.J. Ng, MBChB, MD, FANZCA, FHKAM
jkfng@hku.hk+852 22553303

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026